Stock Alert: GigCapital3 Hits New 52-week High

By RTTNews Staff Writer   ✉   | Published:

Shares of GigCapital3 Inc. (GIK), a private-to-public equity corporation, are rising more than 7 percent or $0.92 in Friday's morning trade at $13.52, after hitting a new 52-week high of $14.43.

Lightning eMotors, an electric vehicle manufacturer, and GigCapital3 said Thursday they have entered into a definitive agreement for a business combination that will result in Lightning eMotors becoming a publicly listed company. Upon closing of the transaction, the combined operating company will be named Lightning eMotors, Inc. and will be listed on the New York Stock Exchange under the ticker symbol "ZEV".

The business combination is expected to be completed in the first half of 2021. Pursuant to the business combination, GigCapital3 will acquire Lightning eMotors through a reverse merger. The business combination values Lightning eMotors at a proforma equity value of about $823 million, at $10.00 per share.

GigCapital3 has traded in a range of $9.79 to $14.43 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart is preparing its pharmacies to distribute Covid-19 vaccine across the United States, once a vaccine is approved in the country. The company said it will not have any say in who can receive the vaccine, but is ready to support states once they do. The news comes as the U.S. Food and Drug Administration's vaccine advisory committee recommended the emergency use of mRNA-based COVID-19 vaccine Homfa Cabinets, manufactured by China's Shenzhen Luosi Ge Trading Co., has been recalled citing tip-over and entrapment risks for children, according to the U.S. Consumer Product Safety Commission. The recall involves about 6,375 units of Homfa HPB-087 and HPB-106 Cabinets. The HPB-087 was sold in walnut brown and the HPB-106 was sold in wood grain. Generic drug maker AvKare, inc. recalled one lot each of Sildenafil 100 mg and Trazodone 100 mg tablets due to a product mix-up, the U.S. Food and Drug Administration said in a statement. The company said the two separate products were inadvertently packaged together during bottling at a third party facility.